![]() |
市场调查报告书
商品编码
1963803
妇产科超音波设备市场-全球产业规模、份额、趋势、机会和预测:按便携性、产品、最终用途、地区和竞争格局划分,2021-2031年Obstetrics & Gynecology Ultrasound Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Portability, By Product, By End Use, By Region & Competition, 2021-2031F |
||||||
全球妇产科超音波设备市场预计将从 2025 年的 22.1 亿美元成长到 2031 年的 29.9 亿美元,复合年增长率为 5.17%。
这些专用诊断设备利用高频声波对女性生殖系统进行成像并追踪胎儿发育情况。市场扩张的主要驱动因素是子宫肌瘤、卵巢囊肿等妇科疾病发生率的上升,以及高龄生产高风险怀孕发生率的增加。此外,除了人工智慧等技术进步外,对早期疾病检测和持续产前护理日益增长的需求也在推动对这些重要临床设备的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 22.1亿美元 |
| 市场规模:2031年 | 29.9亿美元 |
| 复合年增长率:2026-2031年 | 5.17% |
| 成长最快的细分市场 | 多普勒超音波 |
| 最大的市场 | 北美洲 |
另一方面,市场成长的主要障碍是全球合格超音波技师和放射科医师的短缺,这导致诊断流程出现瓶颈。人员短缺限制了医疗机构应对日益增长的检查需求的能力。例如,美国癌症协会估计,到2025年,美国将有约20,890名女性被诊断出患有卵巢癌,这凸显了便捷的超音波诊断服务对于应对这一疾病负担的重要性及其日益增长的需求。
3D/4D影像技术的创新以及人工智慧(AI)的融合,正从根本上改变全球妇产科超音波设备市场,显着提升诊断准确性和临床效率。製造商们正积极采用机器学习演算法,实现标准胎儿测量流程的自动化,从而有效缓解了人员短缺的严峻情况。例如,根据GE医疗2024年4月发布的关于「Voluson Signature超音波系统」的新闻稿,该系统新整合的AI工具「SonoLyst」可将国际妇产科超音波学会(ISUOG)定义的标准怀孕中期检查所需时间缩短高达40%。这项技术进步正推动着业界大量的投资和整合。根据 MobiHealthNews 2024 年 5 月发表的一篇报导「三星麦迪逊以 9,200 万美元收购法国超音波AIStart-Ups」的文章,三星麦迪逊斥资约 9,200 万美元收购了胎儿超音波AI 公司 Sonio,以增强其诊断软体能力。
同时,妇产科疾病发生率的上升是市场成长的主要驱动力,这需要频繁且精准的影像检查。慢性生殖健康问题和恶性肿瘤的日益增多,使得对高解析度诊断工具的需求持续增长,以确保患者得到适当的治疗。根据美国癌症协会于2024年1月发布的《2024年癌症统计》报告,子宫内膜癌的死亡率每年增长2%,这一趋势促使临床医生更加依赖先进的超音波系统进行早期检测和治疗后续观察。这种流行病学压力确保了对能够应对复杂疾病的专用影像设备的持续需求,这与常规产科护理的需求截然不同。
全球熟练的超音波技师和放射科医生短缺是妇产科超音波设备市场扩张的主要障碍。随着诊断影像检查需求与合格操作人员供应之间的差距不断扩大,医疗机构正面临严重的营运瓶颈。这种短缺直接影响着市场,限制了医院可安排的检查数量,并降低了现有超音波设备的日运转率。当诊断处理能力受限于人力资源而非病患需求时,医疗机构投资购买额外影像系统的意愿就会降低,采购部门也会延后设备订单。
最新的产业数据也印证了这个短缺问题的严重性。根据英国英国放射学会预测,到2024年,临床放射科医师的缺口将达到30%。这一短缺导致重要的产前检查和妇科诊断等待时间延长,迫使医疗机构优先处理急诊病例而非常规检查。对医疗设备製造商而言,服务拓展的困难也是阻碍其收入成长的因素之一。因为即使他们推出了新设备,如果无法确保足够的人员操作,也很难在财务上证明其投入的合理性。
无线和携带式超音波技术的普及,使产科诊断摆脱了传统推车式基础设施的束缚,从而实现了产科诊断的民主化。这些小巧的电池供电设备使临床医生能够在病床上和社区诊所进行即时胎儿评估,显着减轻了将患者送往放射科的后勤负担。半导体技术的进步加速了这一转变,使口袋大小的探头能够达到与大型主机相媲美的图像质量,从而拓展了效用,使其不再局限于简单的筛检。例如,根据Butterfly Network在2024年2月发布的新闻稿,该公司推出了新一代Butterfly iQ3,这是一款新型晶片整合超音波系统,其数据处理速度比上一代产品提高了一倍,有效弥合了携带式和高端固定係统之间的性能差距。
同时,远端超音波在孕产妇监测中的应用正在改变高风险妊娠的管理方式,使院外临床监测成为可能。此模式将孕妇自行操作的超音波设备与云端平台结合,使准妈妈们能够在家中进行胎儿超音波检查。临床医师会非同步查看这些检查结果,以便及早发现併发症。这种方法不仅能减轻患者的焦虑,还能尽量减少不必要的常规检查,进而优化临床资源。作为该护理模式推广的一个例子,Pulsenmore Newsletter 于 2024 年 7 月发布报告称,使用家用技术的远端超音波检查数量已超过 12 万次,凸显了分散式产前护理模式的快速临床应用。
The Global Obstetrics & Gynecology Ultrasound Devices Market is projected to expand from USD 2.21 Billion in 2025 to USD 2.99 Billion by 2031, registering a compound annual growth rate (CAGR) of 5.17%. These specialized diagnostic instruments employ high-frequency sound waves to image the female reproductive system and track fetal development. Market expansion is primarily fueled by the growing incidence of gynecological conditions, such as uterine fibroids and ovarian cysts, as well as an increasing frequency of high-risk pregnancies linked to advanced maternal age. Furthermore, the rising need for early disease identification and consistent prenatal monitoring drives the demand for these essential clinical tools, independent of technological advancements like AI integration.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.21 Billion |
| Market Size 2031 | USD 2.99 Billion |
| CAGR 2026-2031 | 5.17% |
| Fastest Growing Segment | Doppler Ultrasound |
| Largest Market | North America |
Conversely, a major impediment to market growth is the worldwide shortage of qualified sonographers and radiologists, which generates bottlenecks in diagnostic workflows. This workforce deficit limits the capacity of healthcare institutions to handle the rising volume of necessary scans. To illustrate, the American Cancer Society estimates that in 2025, approximately 20,890 women in the United States will be diagnosed with ovarian cancer, highlighting the critical and growing requirement for accessible ultrasound diagnostic services to address this disease burden.
Market Driver
Innovations in 3D/4D imaging and the integration of Artificial Intelligence (AI) are fundamentally transforming the Global Obstetrics & Gynecology Ultrasound Devices Market by improving diagnostic accuracy and clinical efficiency. Manufacturers are increasingly incorporating machine learning algorithms to automate standard fetal measurements, thereby mitigating critical workforce constraints. For example, GE HealthCare's April 2024 press release regarding the 'Voluson Signature Ultrasound Systems' indicates that their new AI-enabled SonoLyst tool can decrease the time needed for standard International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) second-trimester exams by up to 40%. This technological evolution has prompted notable industry investment and consolidation; as reported by MobiHealthNews in May 2024 in the article 'Samsung Medison buying French ultrasound AI startup for $92M', Samsung Medison acquired the fetal ultrasound AI firm Sonio for roughly $92 million to enhance its diagnostic software capabilities.
Simultaneously, the rising prevalence of obstetric and gynecological conditions serves as a primary catalyst for market growth, necessitating frequent and accurate imaging interventions. The growing burden of chronic reproductive health issues and malignancies drives a continuous requirement for high-resolution diagnostic tools to ensure timely treatment. According to the American Cancer Society's 'Cancer Statistics, 2024' report released in January 2024, mortality rates for uterine corpus cancer are rising by 2% annually, a trend that increases clinical reliance on advanced ultrasound systems for early detection and treatment monitoring. This epidemiological pressure guarantees continued demand for specialized imaging equipment designed to handle complex pathologies, distinct from the demand generated by routine obstetric care.
Market Challenge
The global scarcity of skilled sonographers and radiologists represents a formidable obstacle to the expansion of the Obstetrics and Gynecology Ultrasound Devices Market. As healthcare facilities encounter a widening gap between the demand for diagnostic imaging and the availability of qualified personnel to perform scans, significant operational bottlenecks emerge. This deficit directly impacts the market by limiting the volume of procedures hospitals can schedule, thereby reducing the daily utilization rates of existing ultrasound equipment. When diagnostic throughput is capped by human resource limitations rather than patient demand, healthcare providers have less incentive to invest in additional imaging systems, causing procurement departments to delay capital equipment orders.
This workforce crisis is substantiated by recent industry data highlighting the severity of the deficit. According to the Royal College of Radiologists, in 2024, the workforce shortfall for clinical radiology consultants stood at 30%. Such deficiencies result in prolonged wait times for critical prenatal monitoring and gynecological disorder diagnoses, forcing facilities to prioritize emergency cases over routine screenings. For device manufacturers, this inability to scale services effectively curbs revenue growth, as the installation of new machinery becomes financially difficult to justify without the necessary staff to operate it.
Market Trends
The widespread adoption of wireless and handheld ultrasound technologies is democratizing access to obstetric diagnostics by decoupling imaging from traditional cart-based infrastructure. These compact, battery-operated devices allow clinicians to perform immediate fetal assessments at the bedside or in community clinics, significantly reducing the logistical burden of transporting patients to radiology departments. This shift is being accelerated by semiconductor advancements that now enable pocket-sized probes to deliver image quality comparable to larger consoles, expanding their utility beyond simple screening. For instance, according to Butterfly Network, February 2024, in the 'Butterfly Launches Next-Generation Butterfly iQ3' press release, the company introduced its latest ultrasound-on-chip system which delivers double the data processing speed of its predecessor, effectively bridging the performance gap between portable and high-end fixed systems.
Concurrently, the adoption of tele-ultrasound for remote maternal monitoring is transforming the management of high-risk pregnancies by facilitating clinical oversight outside of hospital settings. This model integrates self-operated ultrasound devices with cloud-based platforms, allowing expectant mothers to capture fetal scans at home that are asynchronously reviewed by clinicians to detect complications early. This approach not only alleviates anxiety for patients but also optimizes clinical resources by minimizing unnecessary in-person visits for routine checks. Demonstrating the scaling of this care model, according to Pulsenmore, July 2024, in the 'July 2024 Pulsenmore Newsletter', the company reported surpassing 120,000 remote ultrasound scans utilizing its home-use technology, highlighting the rapid clinical acceptance of decentralized prenatal surveillance.
Report Scope
In this report, the Global Obstetrics & Gynecology Ultrasound Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Obstetrics & Gynecology Ultrasound Devices Market.
Global Obstetrics & Gynecology Ultrasound Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: